250 tests for your search
Réinitialiser la recherche- Isoelectric focussing - CSF + serum (EPLCR)
- L-carnitine - seminal plasma (LCAR)
- LSD - Lysergic acid diethylamide - biological fluid (LSDD)
- Lyme disease - IgG intrathecal index - CSF + serum (BOINT)
- M-BCR ABL variant - quantification- - whole blood (QMBCR)
- m-BCR-ABL quantification for MDR evaluation - whole blood (BCRX)
- Metformin - biological fluid (METFD)
- Methoxylated derivatives of catecholamines - Free metanephrines (METS)
- Methoxylated derivatives of catecholamines - Free metanephrines - child - Urines (MTAEN)
- Methoxylated derivatives of catecholamines - Free metanephrines - Urine (MTANU)
- MPN-Diagnosis 2 NGS panel(Myeloproliferative neoplasms ) : JAK2/CALR/MPL/CSF3R/SETBP1/SRSF2 (MYSD2)
- MPN-Diagnosis-(DG) NGS panel(Myeloproliferative neoplasms) CARL/CSF3R/ETNK1/JAK2/MPL/SETBP1/SF3B1 (MYSDG)
- Mucopolysaccharides - urines (MPSU)
- Mycobactéria - identification (IDMA)
- Mycoplasma genitalium - Search by gene amplification - 1 sample (MYCBM)
- Mycoplasma genitalium - Search by gene amplification - 2 sample (MYCB2)
- Mycoplasma genitalium - Search by gene amplification - 3 sample (MYCB3)
- Myosite Markers - serum (SYNTH)
- Naropeine - serum (NARO)
- Neisseria gonorrhoeae - Detection by molecular amplification (NGOBM)
- Neuroendocrine Oncogenetics Panel Target genes : DLST, DNMT3A, EGLN1, EGLN2, EPAS1, FH, GOT2, LZTR1, MAX, MDH2, MEN1, MERTK, MET, NF1, NF2, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLC25A11, SMARCB1, TMEM127, TP53, TSC1, TSC2, VHL (EONEN)
- NGS "COLORECTAL 2"panel : AKT1, ALK, BRAF, CTNNB1, EGFR, HER2, FBXW7, FGFR1, FGFR2, FGFR3, KIT, KRAS, MAP2K1, MET, NRAS, PDGFRA, PIK3CA, PTEN, SMAD4, STK11, TP53 (COLO2)
- NGS "LUNG1" panel: AKT1, ALK, BRAF, DDR2, EGFR, HER2, FGFR1, FGFR2, FGFR3, KIT, KRAS, MAP2K1, MET, NRAS, PDGFRA, PIK3CA, PTEN, STK11, TP53 (POUM2)
- NGS "PAN ORGANE" panel: AKT1, ALK, BRAF, CTNNB1, DDR2, EGFR, ERBB2, ERBB4, FBXW7, FGFR1, FGFR2, FGFR3, KIT, KRAS, MAP2K1, MET, NOTCH1, NRAS, PDGFRA, PIK3CA, PTEN, SMAD4, STK11, TP53 (PAN)
- NGS panel - CLL (Treatment and resistance mutations) BAX/BCL2/BTK/CARD11/EP300/MCL1/NOTCH1/PLCG2/SF3B1/TP53 (LLCTR)
- NGS Panel (Lymphoplasmocytic lymphoma «Waldenström Macroglobulinaemia) ARID1A/BTK/CARD11/CD79A/CD79B/CXCR4/MYD88/NOTCH2/PLCG2/TP53 (LPWAL)
- Nocardia - PCR (NOID)
- Non tuberculosis mycobacteria - identification (BKAT)
- Norovirus - direct diagnosis - PCR - Stools (NORBM)
- Norovirus - screening - Stools (NOROS)
- NSE - Neuron-Specific Enolase - biological fluid (NSED)
- Oncogenetic exome (EXONC)
- Oncogenetic panel digestive tract Targeted genes: APC, BMPR1A, CDH1, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2, POLD1, POLE, PTEN, SMAD4, STK11 (EODIG)
- Oncogenetic panel Lung Target genes : ATM, BAP1, BRCA1, BRCA2, CDKN2A, CHEK2, EGFR, ERBB2, MET, NBN, PRKN, RTEL1, STN1, TP53, VHL (EOPOU)
- Oral anticoagulants : Fluindione - Serum (FLUIN)
- Organic acids - quantitative - urine (ORGU)
- Osteocalcin - serum (OSTEO)
- Pancreatic oncogenetic panel Target genes : APC, ATM, BRCA1, BRCA2, CDK4, CDKN2A, EPCAM, MEN1, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, TP53, VHL (EOPAN)
- Panel Hereditary breast ovarian cancer and prostate Gènes ciblés: ATM, BRCA1, BRCA2, CDH1, EPCAM, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, PTEN , RAD51C, RAD51D, TP53 (EOSOP)
- Panel oncogénétique Rétinoblastome Gène ciblé : RB1 (CUR10)
- Papillomavirus - HPV Détection and Typing of 19 high-risk HPV and 18 low-risk HPV - PCR (HPVBM)
- Parasitology - microscopy - Stools (PARSP)
- Physical analysis - Selles (PHYSP)
- Pneumocystis jirovecii - Quantitative PCR / fungal load (PJICF)
- Polyomavirus BK - viral load (POPCR)
- Pre-eclampsia - risk estimation - serum (PECLA)
- Pregabalin - serum (PREGA)
- Prenatal exome (EXOPN)
- Procalcitonin (PCT)
- Propranolol - Serum (AVLO)